Neutralizing precipitin in the serum of a patient treated with L-asparaginase.
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001215:Asparaginase / Q000009:adverse effects*; D002648:Child; D004342:Drug Hypersensitivity; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed; D006969:Hypersensitivity, Immediate; D005779:Immunodiffusion; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D011234:Precipitins; D012882:Skin Tests
D000970:Antineoplastic Agents; D011234:Precipitins; D001215:Asparaginase